Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-10-1
pubmed:abstractText
Epidermal growth factor receptor (EGFR) mutations are strong determinants of tumor response to EGFR tyrosine kinase inhibitors in non-small cell lung cancers (NSCLCs). Currently available methods of EGFR mutation detection rely on direct sequencing. Here, we describe the use of an alternative way to screen EGFR mutations.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1556-1380
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1096-103
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18827604-Adenocarcinoma, pubmed-meshheading:18827604-Adult, pubmed-meshheading:18827604-Aged, pubmed-meshheading:18827604-Aged, 80 and over, pubmed-meshheading:18827604-Carcinoma, Large Cell, pubmed-meshheading:18827604-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:18827604-Carcinoma, Squamous Cell, pubmed-meshheading:18827604-DNA, Neoplasm, pubmed-meshheading:18827604-Female, pubmed-meshheading:18827604-Genetic Testing, pubmed-meshheading:18827604-Humans, pubmed-meshheading:18827604-Lung Neoplasms, pubmed-meshheading:18827604-Male, pubmed-meshheading:18827604-Middle Aged, pubmed-meshheading:18827604-Mutation, pubmed-meshheading:18827604-Neoplasm Staging, pubmed-meshheading:18827604-Polymorphism, Restriction Fragment Length, pubmed-meshheading:18827604-Protein Kinase Inhibitors, pubmed-meshheading:18827604-Quinazolines, pubmed-meshheading:18827604-Receptor, Epidermal Growth Factor, pubmed-meshheading:18827604-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients.
pubmed:affiliation
Department of Internal Medicine, Hino Municipal Hospital, Hino, Tokyo, Japan.
pubmed:publicationType
Journal Article